Projects per year
Personal profile
Personal profile
Dr. Raj Satkunasivam is a fellowship-trained urologic oncologist with a focus on minimally invasive and robotic approaches to the treatment of genito-urinary malignancies. His practice includes minimally invasive and robotic surgical techniques for kidney, bladder, prostate, adrenal and testicular cancers. He is the Director of Advanced Laparoscopic and Robotic Surgery at the Houston Methodist Institute for Technology, Innovation, and Education (MITIE).
Dr. Satkunasivam received his medical degree from the University of Toronto and completed his urology residency also at the University of Toronto. He pursued sub-specialty fellowship training in urologic oncology, advanced robotic and laparoscopic surgery at the University of Southern California, where he developed novel techniques for robotic kidney-sparing surgery (partial nephrectomy) and robotic bladder cancer surgery with entirely robotic (intra-corporeal) urinary reconstruction.
Research interests
Prior to joining Houston Methodist Hospital, Dr. Satkunasivam was an Assistant Professor and Surgeon Investigator at the University of Toronto's Odette Cancer Center at Sunnybrook Hospital. He holds a Master of Science in Health Services Research from the Department of Preventive Medicine, University of Southern California. His research is focused on the clinical epidemiology of genito-urinary malignancies, specifically in identifying novel risk factors, improving individualized risk assessment and in assessing the comparative effectiveness of treatments. His research also examines outcomes and quality of surgical care, and novel strategies to improve the care of complex surgical patients. He is currently an Assistant Professor in the Houston Methodist Academic Institute and a Health Services Researcher in the Center for Outcomes Research at Houston Methodist Hospital.
External positions
Associate Professor of Urology, Weill Cornell Medical College
Oct 1 2021 → …
Research Area Keywords
- Cancer
- Outcomes, Quality & Health Care Performance
- Clinical Translation & Trials
- Clinical Care
Free-text keywords
- Urologic oncology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Molecular Analysis of tumors and liquid biopsies in Patients undergoing standard treatment for Kidney Cancer and correlation to clinical outcomes
Miles, B. J. (Key Personnel) & Satkunasivam, R. (Key Personnel)
8/26/24 → …
Project: Clinical Trial
-
Molecular Analysis of tumors and liquid biopsies in Patients undergoing standard treatment for Bladder Cancer and correlation to clinical outcomes (MAP Bladder)
Satkunasivam, R. (PI), Chan, K. S. (Key Personnel) & Miles, B. J. (Key Personnel)
4/9/24 → …
Project: Clinical Trial
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive MIBC and High-Risk NMIBC Patients who are BCG Naïve or Received Incomplete BCG Treatment
Satkunasivam, R. (PI) & Miles, B. J. (Key Personnel)
5/31/23 → …
Project: Clinical Trial
-
Association Between Anesthesiologist Sex and Patients' Postoperative Outcomes: A Population-based Cohort Study
Jerath, A., Satkunasivam, R., Kaneshwaran, K., Aminoltejari, K., Chang, A., MacDonell, D. S. Y., Kealey, A., Ladowski, S., Sarmah, A., Flexman, A. M., Lorello, G. R., Nabecker, S., Coburn, N., Conn, L. G., Klaassen, Z., Ranganathan, S., Riveros, C., McCartney, C. J. L., Detsky, A. S. & Wallis, C. J. D., Apr 1 2024, In: Annals of surgery. 279, 4, p. 569-574 6 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience
Ranganathan, S., Riveros, C., Xu, S., Hu, S., Geng, M., Huang, E., Melchiode, Z., Zhang, J., Efstathiou, E., Chan, K. S., Wallis, C. J. D., Sonpavde, G. & Satkunasivam, R., Sep 1 2024, In: Urologic Oncology: Seminars and Original Investigations. 42, 9, p. 291.e13-291.e25Research output: Contribution to journal › Article › peer-review
-
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C., Ranganathan, S., Haque, W., Huang, E., Xu, J., Kulkarni, G. S., Geng, M., Anis, M., Muhammad, T., Chan, K. S., Farach, A., Teh, B. S., Miles, B. J., Klaassen, Z., Sonpavde, G. P., Wallis, C. J. D. & Satkunasivam, R., Feb 2024, In: Journal of the Canadian Urological Association. 18, 2, p. 17-24 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database
Melchiode, Z., Hu, S., Xu, J., Riveros, C., Farooq, S., Ranganathan, S., Huang, E., Miles, B. J., Kaushik, D., Wallis, C. J. D. & Satkunasivam, R., Oct 1 2024, In: Urologic Oncology: Seminars and Original Investigations. 42, 10, p. 332.e11-332.e19Research output: Contribution to journal › Article › peer-review
-
Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice
Nguyen, D. D., Satkunasivam, R. & Wallis, C. J. D., Feb 1 2024, In: European Urology Oncology. 7, 1, p. 25-26 2 p.Research output: Contribution to journal › Article › peer-review